HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

496.742

-9.333-1.84%

Number of Gainers:4

Number of Losers:27

Number of Flat:2

PE:- -

High:517.538

Open:506.335

Low:493.809

Close:506.075

Volume:101.78M

Turnover:2.95B

Market Cap:316.77B

Float Cap:282.76B

Loading ...

Antengene Sets Board Meeting to Review Interim Results

Revenue Growth of Up to 23.1% Drives 19% Surge in PEIJIA-B Shares

Biotech Firm JACOBIO-B Anticipates First-Ever Profit of at Least RMB 600 Million

Ascletis Pharma Begins Obesity Drug Candidate Trial

MT Newswires Live

Jacobio Pharmaceuticals Sees Significant Growth in Hy Revenue

THOMSON REUTERS

Jacobio Pharmaceuticals - Expects Net Profit of not Less than Rmb600 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS

Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum

Market Trends Consolidate: Multiple Healthcare Stocks Display 'Pair' Patterns, Here's What It Could Mean

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: Asc36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and Asc36_35Fdc Once-Monthly Injection, a Co-Formulation of Asc36 and Glp-1R/Gipr Peptide Agonist Asc35

THOMSON REUTERS

Ascletis-B Launches Two Phase 1 Obesity Studies in the United States

Ascletis Pharma - U.S. FDA Clears Ind Applications for Asc36 and Asc36_35Fdc

THOMSON REUTERS

Ascletis Says FDA Clears INDs for Obesity Candidates Asc36, Asc36_35fdc

Record-Breaking Surge: WuXi Apptec Sets New Benchmarks, Reviving the Innovative Drug Sector’s Momentum? A New QDII Fund Launches to Capture the Opportunity

Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next

Simply Wall St.

AI-Driven Drug Discovery Nears Reality: From Molecule Generation to Clinical Validation

Drug Innovation and CRO Sectors Surge as Mid-Year Reports Validate Sector Uptrend

AI Drug Discovery Sparks 'Tool Seller' Surge, CXO Giants Break Multiple Records! Innovative Drugs Next in Line? Fund Manager's Latest Analysis!

Sichuan Huiyu Pharmaceutical Secures European Marketing Approvals for Two Injectable Drugs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1574/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":496.74203,"timestamp":1787558899038,"preClose":506.0749,"halted":0,"volume":101777923,"delay":0,"changeRate":-0.018442,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-9.332855,"latestTime":"08-24 16:00:00","open":506.33536,"high":517.53845,"low":493.80942,"amount":2947563098.5,"amplitude":0.046888,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.003657,"increases":4,"decrements":27,"flats":2,"marketCap":316766161904,"floatMarketCap":282758604008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":517.53845,"amplitude":0.046888,"preClose":506.0749,"low":493.80942,"pbRate":"4.109535","latestPrice":496.74203,"volume":101777923,"delay":0,"open":506.33536,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":505.128,"twentyDayClose":497.839,"sixtyDayClose":520.536,"secType":"PLATE","market":"HK","turnoverRate":0.003657,"peRate":-81.157718,"marketCap":316766161904,"floatMarketCap":282758604008,"timestamp":1787558899038,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":4,"down":27,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658957851","title":"Antengene Sets Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658957851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658957851?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:01","pubTimestamp":1786399319,"startTime":"0","endTime":"0","summary":"Antengene sets board meeting to review interim resultsAntengene scheduled a board meeting for Aug. 21, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer:This news brief ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7s7vCl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1191","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190985135","title":"Revenue Growth of Up to 23.1% Drives 19% Surge in PEIJIA-B Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1190985135","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190985135?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:17","pubTimestamp":1786364271,"startTime":"0","endTime":"0","summary":"On August 7, shares of Hong Kong-listed innovative medical device company PEIJIA-B (09996.HK) experienced a sharp surge, closing up 19.3% at HK$5.13.In terms of news, Peijia released its unaudited...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","09996","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162483114","title":"Biotech Firm JACOBIO-B Anticipates First-Ever Profit of at Least RMB 600 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1162483114","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162483114?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363225,"startTime":"0","endTime":"0","summary":"JACOBIO-B (01167) has issued a profit alert, forecasting a net profit of no less than RMB 600 million for the six months ending June 30, 2026. This marks a sharp turnaround from a net loss of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01167","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658193554","title":"Ascletis Pharma Begins Obesity Drug Candidate Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658193554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658193554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:55","pubTimestamp":1786362947,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (HKG:1672) initiated two phase I studies in the U.S. for ASC36 and ASC36_35FDC for the treatment of obesity.The move comes following investigational new drug clearance by the U.S. Food and Drug Administration (FDA), according to a Monday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1574","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935375","title":"Jacobio Pharmaceuticals Sees Significant Growth in Hy Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935375?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:53","pubTimestamp":1786362791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470SQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658370935","title":"Jacobio Pharmaceuticals - Expects Net Profit of not Less than Rmb600 Mln for Six Months Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658370935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658370935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:53","pubTimestamp":1786362791,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","01167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160532640","title":"Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160532640","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160532640?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362646,"startTime":"0","endTime":"0","summary":"Despite the massive subscription for Unitree Technology shares today, the market remained unaffected, with Hong Kong stocks jumping 1.05% at the open. With the midterm elections approaching, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0348766576.USD","LU0390135688.USD","BK1103","BK1535","BK1161","LU0314109678.HKD","SG9999001093.SGD","09939","LU0593848301.USD","VXUS","LU1242518857.USD","SGXZ90724238.SGD","BK1544","LU1242518931.SGD","KCAI","BK1198","LU0300738514.USD","LU1813983027.USD","VTHR","LU0300738605.USD","LU0463099449.HKD","LU0348767384.USD","LU2279858448.HKD","BK1227","LU2543165471.USD","QTOC","BK1237","LU0390135506.SGD","BK4585","SG9999001051.SGD","BK1574","SGXZ86797644.SGD","SG9999003461.SGD","LU0244354667.USD","09858","02419","BK4588","HK0000500386.USD","CHAT","BK1515","ARTY","02714","LU2039709279.SGD","LU2213484517.USD","SG9999002950.SGD","LU1188198961.HKD","LU0049112450.USD","SG9999011746.SGD","LU1235295612.USD","LU1046422090.SGD","02259","HK0000252152.HKD","LU0390135332.USD","159938","BK1587","HK0000252160.HKD","AGIX","LU0979878070.USD","02343","LU1171460220.USD","LU1328277881.USD","AIPO","SGXZ62798434.SGD","BK1212","06181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144690241","title":"Market Trends Consolidate: Multiple Healthcare Stocks Display 'Pair' Patterns, Here's What It Could Mean","url":"https://stock-news.laohu8.com/highlight/detail?id=1144690241","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144690241?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:21","pubTimestamp":1786360885,"startTime":"0","endTime":"0","summary":"Today, the three major A-share indices ended with mixed results, with the Shanghai Composite Index marking its fifth consecutive daily gain. At the close, the Shanghai Composite Index and the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980079","title":"Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: Asc36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and Asc36_35Fdc Once-Monthly Injection, a Co-Formulation of Asc36 and Glp-1R/Gipr Peptide Agonist Asc35","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980079?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359615,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470PG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159859212","title":"Ascletis-B Launches Two Phase 1 Obesity Studies in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1159859212","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159859212?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:57","pubTimestamp":1786359439,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced that, following Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA), it has initiated two Phase 1 studies in the United...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","BK1515","01477","BK1161","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658198045","title":"Ascletis Pharma - U.S. FDA Clears Ind Applications for Asc36 and Asc36_35Fdc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658198045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658198045?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:50","pubTimestamp":1786359050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470MZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01672","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658801059","title":"Ascletis Says FDA Clears INDs for Obesity Candidates Asc36, Asc36_35fdc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658801059","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658801059?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:50","pubTimestamp":1786359049,"startTime":"0","endTime":"0","summary":"Ascletis says FDA clears INDs for obesity candidates ASC36, ASC36_35FDCAscletis received US FDA IND clearance to start two Phase 1 obesity studies of ASC36 and monthly fixed-dose combo ASC36_35FDC.Tri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL55q8X6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160559566","title":"Record-Breaking Surge: WuXi Apptec Sets New Benchmarks, Reviving the Innovative Drug Sector’s Momentum? A New QDII Fund Launches to Capture the Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1160559566","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160559566?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:36","pubTimestamp":1786358172,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector was jolted awake in early August by a stunning half-year earnings report. The company posted a revenue of 288.97 billion yuan, a 38.93% year-on-year increase, and a net...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","IE00BPRC5H50.USD","LU1770034418.SGD","09939","LU1251922891.USD","LU1808992512.USD","LU1997245094.SGD","LU0708995583.HKD","LU1969619763.USD","LU1997245177.USD","BK0216","LU1979443071.USD","LU2045819591.USD","LU0052750758.USD","LU1303224171.USD","LU1719994722.HKD","LU2242644610.SGD","LU2488822045.USD","06978","LU1934453819.USD","LU0348766576.USD","BK1583","BK1515","LU0700851271.USD","MEDX","LU0456842615.SGD","02359","LU2125910500.SGD","BK1576","LU1997244956.HKD","BK1141","LU0320764599.SGD","LU0611395673.USD","603259","LU0348767384.USD","LU2495084118.USD","LU2328871848.SGD","LNGR","159938","IBBQ","IE00B5MMRT66.SGD","LU1046422090.SGD","IE00B543WZ88.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935955","title":"Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935955","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935955?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:35","pubTimestamp":1786358118,"startTime":"0","endTime":"0","summary":"In August 2026, InnoCare Pharma announced that its BTK inhibitor orelabrutinib, combined with BCL2 inhibitor mesutoclax, received Breakthrough Therapy Designation from China’s CDE for previously treated marginal zone lymphoma, following clinical data showing a 100% overall response rate and a favorable safety profile.\nThis recognition, alongside earlier positive Phase III results for TYK2 inhibitor fadeucravacitinib in moderate-to-severe plaque psoriasis, underscores InnoCare’s push to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-innocare-pharma-sehk9969-is-up-129-after-dual-breakthrou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/why-innocare-pharma-sehk9969-is-up-129-after-dual-breakthrou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIX","BK1161","QTOC","ARTY","AIPO","VTHR","CHAT","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100336884","title":"AI-Driven Drug Discovery Nears Reality: From Molecule Generation to Clinical Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=1100336884","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100336884?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:31","pubTimestamp":1786357878,"startTime":"0","endTime":"0","summary":"If traditional drug development is like trying countless keys in the dark, AI's first step is not to open the door itself, but to prioritize the keys most likely to fit. In 2026, several strong...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","ARTY","BK1191","AGIX","01477","BK1574","VTHR","QTOC","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152511864","title":"Drug Innovation and CRO Sectors Surge as Mid-Year Reports Validate Sector Uptrend","url":"https://stock-news.laohu8.com/highlight/detail?id=1152511864","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152511864?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:51","pubTimestamp":1786355469,"startTime":"0","endTime":"0","summary":"As of August 7, 22 innovative drug companies have released their first-half performance reports for 2026, with a generally positive trend. Among them, 12 reported year-on-year growth, 3 turned...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WX","159992","LNGR","CXO","BK1574","06978","BK1161","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151027030","title":"AI Drug Discovery Sparks 'Tool Seller' Surge, CXO Giants Break Multiple Records! Innovative Drugs Next in Line? Fund Manager's Latest Analysis!","url":"https://stock-news.laohu8.com/highlight/detail?id=1151027030","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151027030?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:50","pubTimestamp":1786355446,"startTime":"0","endTime":"0","summary":"Since August, Hong Kong's innovative drug supply chain has reignited, with CXO stocks taking the lead. On August 10, WuXi AppTec H-shares hit a new all-time high, pushing its market cap above 600...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","159992","IBBQ","BK1191","QTOC","ARTY","01477","WX","CXO","VTHR","AGIX","AIPO","BK1574","LNGR","BK1161","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190555236","title":"Sichuan Huiyu Pharmaceutical Secures European Marketing Approvals for Two Injectable Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1190555236","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190555236?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:40","pubTimestamp":1786354825,"startTime":"0","endTime":"0","summary":"Sichuan Huiyu Pharmaceutical Co.,Ltd. (688553.SH) has announced that its subsidiary, Seacross (Europe) Pharma Ltd., has recently received marketing authorizations from regulatory authorities in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688553","BK1191","01477","BK1574","BK0239","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":14,"totalSize":278,"code":"91000000","status":"200"}]}}